KIMBERLY SPIRES: Open Payments
NPI 1194278879 · ORANGEBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 27 payments from 10 companies in 2025. Trend: 2023 $204 · 2024 $304 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $141 |
| ABBVIE INC. | 11 | $141 |
| Exact Sciences Corporation | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Theratechnologies Inc. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Indivior Inc. | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $12 |
Products named: Ozempic, VRAYLAR, The Cologuard Plus Collection Kit, AIRSUPRA, EGRIFTA, Veozah, MOUNJARO, Cologuard Collection Kit.
Industry payments across SC — which companies pay providers there.
